MedPath

Evaluation of Therapeutic Effect of Tranexamic Acid Infusion on Intraparenchymal Hemorrhage

Phase 2
Conditions
Intracranial injury.
Focal brain injury
Registration Number
IRCT2016031427051N1
Lead Sponsor
Vice challenge for research of Ahvaz Jondishapour University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion criteria : age over 18 years old; attendance to the emergency room within the first 8 hours of the accident; trauma to the head with Intraparenchymal hemorrhage (IPH) on brain CT scan; absence of significant extra-cranial hemorrhage such as intra-abdominal hemorrhage; absence of fracture or deformity of limbs; absence of subarachnoid hemorrhage; absence of hematuria; absence of known coagulopathy; necessity to perform neurosurgery in clinical evaluation and according to neurosurgeon's opinion. Exclusion criteria :Existence of pregnancy; the presence of other types of intracranial hemorrhage other than intraparenchymal hematoma; need to FFP or massive whole blood transfusion; hematuria; presence of subarachnoid hemorrhage; usage of anticoagulant drugs and aspirin.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of bleeding during surgery. Timepoint: during surgery. Method of measurement: Suctioned blood volume measurement.
Secondary Outcome Measures
NameTimeMethod
Duration of hospitalization. Timepoint: After surgery. Method of measurement: according to patient's documents.;Result of functional Test. Timepoint: 28 days after surgery or at time of discharge. Method of measurement: Examinations conducted by researcher.;Duration of surgery. Timepoint: At time of surgery. Method of measurement: Document of patients.
© Copyright 2025. All Rights Reserved by MedPath